If you are trying to figure out whether Insmed's current share price makes sense, you are in the right place for a clear look at what the market might be pricing in. The stock trades at US$148.75 ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Insmed (INSM) reports results for the ...

With the business potentially at an important milestone, we thought we'd take a closer look at Insmed Incorporated's ...

Investors in Insmed Inc (Symbol: INSM) saw new options become available today, for the December 2024 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is ...

TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” third-quarter 2024 investor letter. A copy of the letter can be downloaded here.

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Mid Cap Growth Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the ...

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Insmed Incorporated (“Insmed” or “the Company”) (NASDAQ: INSM) ...

Insmed Inc. Annual cash flow by MarketWatch. View INSM net cash flow, operating cash flow, operating expenses and cash dividends.

Insmed Incorporated (NASDAQ:INSM) shares are trading higher after the company released topline results from its Phase 3 ARISE study of ARIKAYCE in patients with newly diagnosed or recurrent ...

Investors in Insmed Inc (Symbol: INSM) saw new options begin trading today, for the July 2024 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the ...